Track NeuBase Therapeutics, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

NeuBase Therapeutics, Inc. NBSE · Stock Open NeuBase Therapeutics, Inc. in new tab

0.3780 USD
Add to portfolio
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for NeuBase Therapeutics, Inc. (NBSE)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

NeuBase Therapeutics, Inc. Analysis (NBSE)

United States Health Care Stock

Is NeuBase Therapeutics, Inc. a good investment? NeuBase Therapeutics, Inc. (NBSE) is currently trading at 0.3780 USD.

Investor FAQ

Does NeuBase Therapeutics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is NeuBase Therapeutics, Inc.?

NeuBase Therapeutics, Inc. is classified as a Stock.

Company Profile

No detailed summary available for NeuBase Therapeutics, Inc..

Trades
No dividend information available for this instrument.

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion